Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.
Install App?
Innovations in Pharmaceutical Technology (IPT)
www.iptonline.com
This is how the Install App dialog will look like once your App goes live.
10 January 2023 -- Luxembourg -- CordenPharma is pleased to announce the signing of a multi-year agreement commencing in 2023 for the contract manufacturing of a large-volume peptide at its CordenPharma Colorado facility.
The manufacturing agreement will potentially cover a value of ca. USD 1 billion, depending on actual production over the term of the agreement, and will support the launch of an innovative peptide. The companies have agreed not to disclose additional details and respect customer confidentiality.
Dr Michael Quirmbach, CEO & President of CordenPharma, commented: “We are very excited about the trust our customer has placed in CordenPharma, and are pleased to continue supporting the commercial manufacturing of this innovative peptide at our CordenPharma Colorado (US) site, which is perfectly equipped for producing these types of complex molecules.
As part of our commitment, we plan to further expand both our large and medium-scale peptide manufacturing capacity at our Colorado and Frankfurt sites, making CordenPharma the leading peptide manufacturing CDMO with full drug product integration, possible via our aseptic fill and finish capabilities in CordenPharma Caponago.”
In parallel, CordenPharma is pursuing a large investment program across its global facility network to expand capacities and technologies in key areas such as Peptides, Lipids, and Injectables, with an overall planned investment of > €200M in 2023.
About CordenPharma
CordenPharma is a full-service partner in the Contract Development & Manufacturing (CDMO) of innovative APIs, Lipid Excipients, and Drug Products. Through a growing network of cGMP facilities across Europe and the US organized under five Technology Platforms - Peptides - Lipids & Carbohydrates - Injectables - Highly Potent & Oncology - Small Molecules - CordenPharma experts translate complex processes and projects at any stage of development into high-value products. For more information about CordenPharma, contact us or visit cordenpharma.com.
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/ec4596b6-cc02-4c93-8bb1-66ceb94fbddd.png?optimizer=image&width=360&aspect_ratio=3:4)
Automata launches LINQ Cloud software to scale and manage lab automation from anywhere
24 May 2023 -- London, UK -- Automata, a leading company powering life science labs to fully automate their workflows, today launches LINQ Cloud: cutting-edge laboratory automation software. LINQ Cloud connects a lab’s physical and digital environment together, enabling life science organisations to scale while reducing the manual workload for scientists.
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/18bff7dd-0e97-4096-8867-aa9304b4bbe2.png?optimizer=image&width=360&aspect_ratio=3:4)
Enhanced user experience with the latest release of Scitara’s iPaaS for science, now SOC2 certified
24 May 2023 -- Massachusetts, US -- Laboratory digital transformation pioneer, Scitara, announces new releases to its SOC 2-certified Digital Lab Exchange DLX cloud platform to improve the user experience, enhance instrument connectivity and deliver new automation to the lab.
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/f99a5b68-5d67-4f3a-853b-604dcc5882c3.png?optimizer=image&width=360&aspect_ratio=3:4)
CatSci Launch New and Improved SmartPath, a Digital Risk Assessment Tool To Maximise SM Success
23 May 2023 -- Cardiff, UK -- CatSci, an award-winning innovation partner for medicines development, are proud to announce the launch of their new and improved SmartPath. SmartPath is an innovative digital risk assessment tool that highlights the risks de-railing users’ API success and offers tailored Smart mitigation strategies on the project, formulation and API properties.
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/939428fa-14bd-4b75-8930-d685348835da.png?optimizer=image&width=360&aspect_ratio=3:4)
Sphere Fluidics updates brand identity to align with ambitious, global commercial growth strategy
23 May 2023 -- Cambridge, UK -- Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced the introduction of new branding to align with its ambitious global commercial growth strategy.
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/c79b699a-631c-4bfd-95ec-f38c8a60f665.png?optimizer=image&width=360&aspect_ratio=3:4)
Aurigene Pharma Services to expand biologics CDMO capacity with a new biomanufacturing facility
22 May 2023 -- Hyderabad, India -- Aurigene Pharmaceutical Services, a contract research, development and manufacturing services organisation and a step-down subsidiary of Dr Reddy's Laboratories, announces the construction of a state-of-the art development and manufacturing facility for therapeutic proteins, antibodies and viral vectors.
1
Human-Centred Design: From Inception to Integration
IPT sat down with Dr Chris Vincent at PDD, to understand more about the digital innovations that are leading design and whether technologies like Extended Reality (XR) can be beneficial to the process
2
The Importance of Temperature Control in Pharmaceutical Analysis
As technology within the analysis sphere continues to evolve, temperature control is becoming increasingly important for drug discovery and research
3
Providing Support Throughout the Patient Journey
Concierge services are critical to helping patients navigate technology and other logistics in a decentralised clinical trial. How best can they be implemented?
